Clarification sought from Neuland Laboratories

01 Mar 2017 Evaluate

The Exchange has sought clarification from Neuland Laboratories on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017, ‘US FDA grants priority review for SD-809’.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

14542.75 -79.00 (-0.54%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.